M. Souri

发表

D-3-hydroxyacyl-CoA dehydratase/D-3-hydroxyacyl-CoA dehydrogenase bifunctional protein deficiency: a newly identified peroxisomal disorder.

T. Hashimoto, S. Miyazawa, Y. Suzuki, 1997, American journal of human genetics.

Genes for the Human Mitochondrial Trifunctional Protein α- and β-Subunits Are Divergently Transcribed from a Common Promoter Region*

T. Hashimoto, T. Aoyama, K. Orii, 1999, The Journal of Biological Chemistry.

Catalytic and FAD-binding Residues of Mitochondrial Very Long Chain Acyl-Coenzyme A Dehydrogenase*

T. Hashimoto, T. Aoyama, G. Cox, 1998, The Journal of Biological Chemistry.

Cloning of human very-long-chain acyl-coenzyme A dehydrogenase and molecular characterization of its deficiency in two patients.

T. Aoyama, K. Tanaka, T. Hashimoto, 1995, American journal of human genetics.

Purification of human very-long-chain acyl-coenzyme A dehydrogenase and characterization of its deficiency in seven patients.

William, T. Aoyama, K. Tanaka, 1995, The Journal of clinical investigation.

Non-autoimmune combined factor XIII A and B subunit deficiencies in rheumatoid arthritis patients treated with anti-interleukin-6 receptor monoclonal antibody (tocilizumab).

A. Ichinose, T. Osaki, M. Souri, 2016, Thrombosis research.

Efficacy of Autologous Plasmin for Idiopathic Macular Hole Surgery

A. Mizota, A. Ichinose, M. Souri, 2005, European journal of ophthalmology.

Association between milk and yogurt intake and mortality: a community-based cohort study (Yamagata study)

Masafumi Watanabe, Y. Ueno, T. Kayama, 2021, BMC Nutrition.

Relationship between social support status and mortality in a community-based population: a prospective observational study (Yamagata study)

H. Yamashita, Masafumi Watanabe, Y. Ueno, 2020, BMC Public Health.

Factor XIII transglutaminase supports hematogenous tumor cell metastasis through a mechanism dependent on natural killer cell function

J. Degen, M. Flick, K. Kombrinck, 2008, Journal of thrombosis and haemostasis : JTH.

Acquired von Willebrand Syndrome in a Patient with Multiple Comorbidities, Including MALT Lymphoma with IgA Monoclonal Gammopathy and Hyperviscosity Syndrome

T. Ikezoe, Masahiko Fukatsu, Y. Hashimoto, 2022, Internal medicine.

Very‐long‐chain acyl‐CoA dehydrogenase subunit assembles to the dimer form on mitochondrial inner membrane

T. Aoyama, T. Hashimoto, T. Aoyama, 1998, FEBS letters.

Mutation analysis of very-long-chain acyl-coenzyme A dehydrogenase (VLCAD) deficiency: identification and characterization of mutant VLCAD cDNAs from four patients.

T. Hashimoto, T. Aoyama, K. Orii, 1996, American journal of human genetics.

Peroxisomal acyl-coenzyme A oxidase is a rate-limiting enzyme in a very-long-chain fatty acid beta-oxidation system.

T. Hashimoto, T. Aoyama, M. Souri, 1994, Biochemical and biophysical research communications.

Formation of the enzyme complex in mitochondria is required for function of trifunctional beta-oxidation protein.

S. Hayashi, T. Hashimoto, T. Aoyama, 1996, Biochemical and biophysical research communications.

Transcriptional Regulation of Cell Type-specific Expression of the TATA-less A Subunit Gene for Human Coagulation Factor XIII*

M. Yamamoto, H. Saito, H. Saito, 1999, The Journal of Biological Chemistry.

Retrospective examination of coagulation parameters in 33 patients with autoimmune coagulation factor deficiencies in Japan: A single-center analysis.

Y. Ogawa, A. Ichinose, T. Osaki, 2022, Thrombosis research.

Plasma proteomics associated with autoimmune coagulation factor deficiencies reveals the link between inflammation and autoantibody development

A. Ichinose, T. Osaki, M. Souri, 2022, International Journal of Hematology.

Erratum to: Successful bypass surgery for esophageal carcinoma under adequate factor XIII/13 replacement therapy in a case of intractable autoimmune hemorrhaphilia due to anti-Factor XIII/13 antibodies

K. Ando, S. Ozawa, A. Ichinose, 2016, International Journal of Hematology.

Anti‐factor XIII A subunit (FXIII‐A) autoantibodies block FXIII‐A2B2 assembly and steal FXIII‐A from native FXIII‐A2B2

A. Ichinose, T. Osaki, M. Souri, 2015, Journal of thrombosis and haemostasis : JTH.

Successful bypass surgery for esophageal carcinoma under adequate factor XIII/13 replacement therapy in a case of intractable autoimmune hemorrhaphilia due to anti-Factor XIII/13 antibodies

K. Ando, S. Ozawa, A. Ichinose, 2015, International journal of hematology.

Severe inhibitor-negative acquired factor XIII/13 deficiency with aggressive subdural haemorrhage.

E. Kohmura, K. Minagawa, Y. Katayama, 2013, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Impaired dimer assembly and decreased stability of naturally recurring R260C mutant A subunit for coagulation factor XIII.

V. Yee, A. Ichinose, M. Souri, 2012, Journal of biochemistry.

A short half-life of the administered factor XIII (FXIII) concentrates after the first replacement therapy in a newborn with severe congenital FXIII deficiency

N. Fujii, A. Ichinose, M. Souri, 2012, Thrombosis and Haemostasis.

Male-specific cardiac pathologies in mice lacking either the A or B subunit of factor XIII

M. Souri, 2009 .

Male-specific cardiac pathologies in mice lacking either the A or B subunit of factor XIII

Y. Takeishi, Shiori Koseki-Kuno, M. Yamakawa, 2008, Thrombosis and Haemostasis.

Administration of factor XIII B subunit increased plasma factor XIII A subunit levels in factor XIII B subunit knock-out mice

Shiori Koseki-Kuno, N. Takeda, J. Degen, 2008, International journal of hematology.

Truncated mutant B subunit for factor XIII causes its deficiency due to impaired intracellular transportation.

M. Yamakawa, A. Ichinose, F. Yanai, 2001, Blood.

Molecular and genetic mechanisms of factor XIII A subunit deficiency.

A. Ichinose, M. Souri, T. Izumi, 2000, Seminars in thrombosis and hemostasis.

Successful Management of a Patient with Autoimmune Hemorrhaphilia due to Anti-Factor XIII/13 Antibodies Complicated by Pulmonary Thromboembolism

Y. Nojima, Y. Ogawa, H. Handa, 2017, Acta Haematologica.

Autoimmune Coagulation Factor X Deficiency as a Rare Acquired Hemorrhagic Disorder: A Literature Review

A. Ichinose, T. Osaki, M. Souri, 2021, Thrombosis and Haemostasis.

Pathological coagulation parameters in as many as 54 patients with autoimmune acquired factor XIII deficiency due to anti–factor XIII autoantibodies

A. Ichinose, T. Osaki, M. Souri, 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

Lobar Hemorrhage Induced by Acquired Factor XIII Deficiency in a Patient with Cerebral Amyloid Angiopathy.

T. Yamauchi, K. Kikuta, N. Hosono, 2017, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Report of a patient with chronic intractable autoimmune hemorrhaphilia due to anti-factor XIII/13 antibodies who died of hemorrhage after sustained clinical remission for 3 years

A. Ichinose, T. Kotake, M. Souri, 2015, International Journal of Hematology.

Proteosomal degradation of naturally recurring R260C missense and exon‐IV deletion mutants of factor XIII A‐subunit expressed in mammalian cells

A. Ichinose, W. G. Zhang, M. Souri, 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

Alloantibodies against the B subunit of plasma factor XIII developed in its congenital deficiency

T. Sugihara, H. Wada, A. Ichinose, 2013, Thrombosis and Haemostasis.

Aggressive fatal case of autoimmune hemorrhaphilia resulting from anti-Factor XIII antibodies

A. Ichinose, M. Souri, H. Uesugi, 2013, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Impaired clot retraction in factor XIII A subunit-deficient mice.

A. Ichinose, M. Souri, N. Yamamoto, 2010, Blood.

Sushi domains in the B subunit of factor XIII responsible for oligomer assembly.

A. Ichinose, M. Souri, H. Kaetsu, 2008, Biochemistry.

THROMBOSIS AND HEMOSTASIS Impaired clot retraction in factor XIII A subunit-deficient mice Running head: KASAHARA et al FXIII-A IS REQUIRED FOR CLOT RETRACTION

A. Ichinose, M. Souri, N. Yamamoto, 2009 .

LETTERS TO THE EDITOR: An additional Glu30Lys substitution in the Gla domain of the protein Z gene is not a common polymorphism but a rare mutation, which would cause its deficiency

H. Iwata, A. Ichinose, M. Souri, 2005, Journal of thrombosis and haemostasis : JTH.

Regulation of human protein Z gene expression by liver‐enriched transcription factor HNF‐4α and ubiquitous factor Sp1

H. Iwata, H. Sugawara, A. Ichinose, 2007, Journal of thrombosis and haemostasis : JTH.

A new inhibitor of mitochondrial fatty acid oxidation.

T. Hashimoto, G. Baldwin, M. Souri, 1996, Journal of biochemistry.

A Review of Autoimmune Acquired von Willebrand Factor Deficiency in Japan.

E. Favaloro, A. Ichinose, T. Osaki, 2022, Seminars in thrombosis and hemostasis.

A Review of Coagulation Abnormalities of Autoimmune Acquired Factor V Deficiency with a Focus on Japan

A. Ichinose, T. Osaki, M. Souri, 2021, Seminars in Thrombosis and Hemostasis.

Acquired factor V inhibitor with erythema and eosinophilia in a patient with end-stage renal disease

K. Kohagura, Y. Ohya, A. Ishida, 2022, CEN Case Reports.

A high titer of acquired factor V inhibitor in a hemodialysis patient who developed arterial thrombosis

K. Morikane, A. Ichinose, T. Osaki, 2018, International Journal of Hematology.

Medium Chain 3-Ketoacyl-Coenzyme A Thiolase Deficiency: A New Disorder of Mitochondrial Fatty Acid β-Oxidation

T. Hashimoto, A. Komiyama, T. Aoyama, 1997, Pediatric Research.

Reversal of severe hypertrophic cardiomyopathy and excellent neuropsychologic outcome in very-long-chain acyl-coenzyme A dehydrogenase deficiency.

T. Aoyama, L. Varvogli, T. Hashimoto, 1998, The Journal of pediatrics.

Purification and characterization of two isoforms of chlorogenic acid oxidase from sweet potato cells in suspension culture

D. Arakawa, M. Souri, M. Kojima, 1998 .

Clot retraction is mediated by factor XIII-dependent fibrin-αIIbβ3-myosin axis in platelet sphingomyelin-rich membrane rafts.

S. Kojima, Hidenori Suzuki, Toshihide Kobayashi, 2013, Blood.

R255h Amino acid substitution of protein Z identified in patients with factor V Leiden mutation

Shiori Koseki-Kuno, A. Ichinose, K. Matthes, 2005, British journal of haematology.

A naturally occurring E30Q mutation in the Gla domain of protein Z causes its impaired secretion and subsequent deficiency.

H. Iwata, Shiori Koseki-Kuno, A. Ichinose, 2005, Blood.

Unique secretion mode of human protein Z: its Gla domain is responsible for inefficient, vitamin K-dependent and warfarin-sensitive secretion.

H. Iwata, A. Ichinose, M. Souri, 2009, Blood.

Increase in the plasma levels of protein Z-dependent protease inhibitor in normal pregnancies but not in non-pregnant patients with unexplained recurrent miscarriage

J. Meijers, M. Sugiura-Ogasawara, A. Ichinose, 2012, Thrombosis and Haemostasis.

Important roles of the human leukocyte antigen class I and II molecules and their associated genes in the autoimmune coagulation factor XIII deficiency via whole-exome sequencing analysis

A. Ichinose, T. Osaki, M. Souri, 2021, PloS one.

Complete remission achieved by steroid pulse therapy following rituximab treatment in a case with autoimmune haemorrhaphilia due to anti-factor XIII antibodies

Y. Nojima, Y. Ogawa, H. Handa, 2014, Thrombosis and Haemostasis.

As many as 12 cases with haemorrhagic acquired factor XIII deficiency due to its inhibitors were recently found in Japan

A. Ichinose, M. Souri, 2011, Thrombosis and Haemostasis.

Autoimmune Acquired Factor XIII/13 Deficiency after SARS-CoV-2 mRNA Vaccination

K. Aihara, M. Abe, A. Ichinose, 2022, Thrombosis and haemostasis.

Reduced difference of α2-plasmin inhibitor levels between plasma and serum in patients with severe factor XIII deficiency, including autoimmune hemorrhaphilia due to anti-factor XIII antibodies

A. Ichinose, M. Souri, 2011, International Journal of Hematology.

Generation and Application of Rat Monoclonal Antibodies Specific for a Human Blood Coagulation Protein: von Willebrand Factor.

A. Ichinose, T. Osaki, C. Yokoyama, 2019, Monoclonal antibodies in immunodiagnosis and immunotherapy.

Unmet Need for Reliable Immunological Detection Method for Anti-von Willebrand Factor Autoantibodies

A. Ichinose, T. Osaki, C. Yokoyama, 2022, Thrombosis and Haemostasis.

Factors associated with health intentions and behaviour among health checkup participants in Japan

Y. Ueno, T. Kayama, Natsuko Suzuki, 2021, Scientific Reports.

Structure of D-3-hydroxyacyl-CoA dehydratase/D-3-hydroxyacyl-CoA dehydrogenase bifunctional protein.

T. Hashimoto, S. Miyazawa, L. L. Jiang, 1997, Journal of biochemistry.

Rapid immunochromatographic test for detection of anti-factor XIII A subunit antibodies can diagnose 90 % of cases with autoimmune haemorrhaphilia XIII/13

A. Ichinose, M. Souri, Y. Magari, 2015, Thrombosis and Haemostasis.

Molecular cloning and functional expression of a human peroxisomal acyl-coenzyme A oxidase.

T. Hashimoto, T. Aoyama, Y. Suzuki, 1994, Biochemical and biophysical research communications.

Clinical features of 32 new Japanese cases with autoimmune haemorrha‐philia due to anti‐factor XIII antibodies

A. Ichinose, T. Osaki, M. Souri, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

Genomic DNA organization of human mitochondrial very-long-chain acyl-CoA dehydrogenase and mutation analysis.

T. Hashimoto, T. Aoyama, N. Kondo, 1995, Biochemical and biophysical research communications.

Use of Autologous Plasmin during Vitrectomy for Diabetic Maculopathy

A. Mizota, A. Ichinose, M. Souri, 2006, European journal of ophthalmology.

[Preparation of high-purity and safe autologous plasmin and its clinical application].

A. Ichinose, M. Souri, Minoru Tanaka, 2003, Nippon Ganka Gakkai zasshi.

Multiple novel transcripts for apolipoprotein(a)-related gene II generated by alternative splicing in tissue- and cell type-specific manners.

N. Takabatake, A. Ichinose, M. Souri, 1998, Journal of Biochemistry (Tokyo).

First and fatal case of autoimmune acquired factor XIII/13 deficiency after COVID‐19/SARS‐CoV‐2 vaccination

Y. Kanisawa, A. Ichinose, M. Souri, 2021, American journal of hematology.

Molecular pathogenesis of plasminogen Hakodate: the second Japanese family case of severe type I plasminogen deficiency manifested late-onset multi-organic chronic pseudomembranous mucositis

R. Law, A. Ichinose, T. Osaki, 2016, Journal of Thrombosis and Thrombolysis.

The Non-catalytic B Subunit of Coagulation Factor XIII Accelerates Fibrin Cross-linking*

A. Ichinose, T. Osaki, M. Souri, 2015, The Journal of Biological Chemistry.

Relationship between structure and substrate-chain-length specificity of mitochondrial very-long-chain acyl-coenzyme A dehydrogenase.

T. Aoyama, T. Hashimoto, T. Aoyama, 1998, European journal of biochemistry.

Novel Immunochromatographic Test for Anti-factor XIII B Subunit Autoantibodies to Diagnose Autoimmune Acquired Factor XIII Deficiency

A. Ichinose, T. Osaki, C. Yokoyama, 2022, Thrombosis and Haemostasis.

Antibodies against Noncatalytic B Subunit of Factor XIII Inhibit Activation of Factor XIII and Fibrin Crosslinking

A. Ichinose, T. Osaki, C. Yokoyama, 2022, Thrombosis and Haemostasis.

A Founder Effect Is Proposed for Factor XIII B Subunit Deficiency Caused by the Insertion of Triplet AAC in Exon III Encoding the Second Sushi Domain

A. Girolami, A. Ichinose, M. Souri, 1998, Thrombosis and Haemostasis.

Successful treatment of chronic disseminated intravascular coagulation using recombinant human soluble thrombomodulin in a dialysis patient with dissecting aortic aneurysm.

T. Kurihara, A. Ichinose, T. Hayakawa, 2014, [Rinsho ketsueki] The Japanese journal of clinical hematology.

[Recurrence of acquired factor V inhibitor after four years of remission].

Y. Ogawa, H. Handa, M. Murakami, 2019, [Rinsho ketsueki] The Japanese journal of clinical hematology.

A quantitative method for cDNA-directed expression in cultured mammalian cells.

T. Aoyama, T. Hashimoto, M. Souri, 1995, Analytical biochemistry.

Molecular modeling predicts structural changes in the A subunit of factor XIII caused by two novel mutations identified in a neonate with severe congenital factor XIII deficiency.

N. Fujii, V. Yee, A. Ichinose, 2012, Thrombosis research.

Impaired protein folding, dimer formation, and heterotetramer assembly cause intra- and extracellular instability of a Y283C mutant of the A subunit for coagulation factor XIII.

A. Ichinose, M. Souri, 2001, Biochemistry.

Novel Y283C mutation of the A subunit for coagulation factor XIII: molecular modelling predicts its impaired protein folding and dimer formation

V. Yee, G. Castaman, A. Ichinose, 2001, British journal of haematology.

Identification of non‐neutralizing anti‐factor X autoantibodies in three Japanese cases of autoimmune acquired factor X deficiency

Y. Ogawa, M. Mori, Y. Shimura, 2022, Haemophilia : the official journal of the World Federation of Hemophilia.

Complete remission in a bleeding patient with idiopathic autoimmune factor X deficiency caused by non‐neutralizing anti‐factor X autoantibody

K. Morikane, M. Mori, A. Ichinose, 2019, Haemophilia : the official journal of the World Federation of Hemophilia.

Impaired clot retraction in factor XIII A subunit-deficient mice.

A. Ichinose, M. Souri, N. Yamamoto, 2010, Blood.

Detection of factor XIII inhibitors in 33 patients with autoimmune factor XIII deficiency in Japan.

T. Osaki, M. Souri, Akitada Ichinose, 2024, International journal of hematology.

Diagnosis and Treatment of Autoimmune Acquired Coagulation Factor Deficiencies: An Evidence-Based Review of Japanese Practice

T. Osaki, M. Souri, Akitada Ichinose, 2024, Seminars in Thrombosis and Hemostasis.

Rapid immunochromatographic test for detection of anti-factor XIII A subunit antibodies can diagnose 90 % of cases with autoimmune haemorrhaphilia XIII/13

A. Ichinose, M. Souri, Y. Magari, 2015, Thrombosis and Haemostasis.